🌸 Take the first dose at bedtime — CORRECT
🌸 Terazosin is an alpha₁-adrenergic blocker that relaxes smooth muscle in the prostate and bladder neck, improving urinary flow in clients with BPH.
🌸 Alpha₁ blockade also causes peripheral vasodilation, which can lower blood pressure.
🌸 The medication can produce a pronounced first-dose effect, especially when therapy is initiated.
🌸 This first-dose effect may cause orthostatic hypotension, dizziness, weakness, or syncope.
🌸 Taking the first dose at bedtime decreases the risk of injury if dizziness or fainting occurs.
🌸 The client should avoid driving or performing hazardous activities until the response to the medication is known.
🌸 Blood pressure should be monitored during initiation and dose adjustments because hypotension may occur.
🌸 Bedtime administration is therefore an important safety strategy when beginning terazosin therapy.
🌸 Get up slowly from a sitting position — CORRECT
🌸 Terazosin can cause orthostatic hypotension when the client changes position quickly.
🌸 Rising slowly gives the cardiovascular system time to adjust to changes in blood pressure.
🌸 The client should first sit at the edge of the bed before standing, especially after lying down for a prolonged period.
🌸 Sudden standing can cause dizziness, lightheadedness, or syncope.
🌸 Older adults may be particularly vulnerable to falls associated with alpha-blocker therapy.
🌸 The client should use support when standing if dizziness occurs.
🌸 Adequate fall-prevention teaching is especially important during the first several days of therapy.
🌸 Slow position changes help reduce the risk of injury from hypotension-related falls.
🌸 Contact the clinic if palpitations occur — CORRECT
🌸 Terazosin can cause reflex tachycardia or palpitations as a response to peripheral vasodilation.
🌸 Palpitations may indicate an exaggerated cardiovascular response to the medication.
🌸 The client should report persistent or significant palpitations to the healthcare provider.
🌸 The nurse should also teach the client to report fainting, severe dizziness, or chest discomfort.
🌸 Cardiovascular symptoms warrant evaluation because dose adjustment may be needed.
🌸 Monitoring is particularly important in clients who also take other antihypertensive medications.
🌸 The nurse should reinforce that new cardiac symptoms should not simply be ignored as expected effects.
🌸 Reporting palpitations allows early assessment for tachycardia or hemodynamic instability.